Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Comparative effects of SOM-230 and octreotide on GH and prolactin release

June 27, 2002

First-in-class SARM with strong anabolic effects characterized at ENDO 2002

June 27, 2002

AMG-073 provides long-term benefits in primary hyperparathyroidism

June 27, 2002

Acyline suppresses testosterone in men for at least 19 days with minimal side effects

June 27, 2002

Ixion receives grant for stem cell research in diabetes

June 27, 2002

Use of LY-333531 in the treatment of diabetic complications

June 27, 2002

Metformin XT is equivalent to immediate-release metformin in the treatment of type 2 diabetes

June 27, 2002

Novel PTP1B inhibitors in early development at Japan Tobacco

June 26, 2002

BIM-51077, a stable GLP-1 analogue, shows potential in the management of type 2 diabetes

June 26, 2002

BVT-2733 tested in three animal models of type 2 diabetes

June 26, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...